{
	"kja6iz95Text": "Eight-week double-blind treatment period",
	"kja6iz96Text": "McInt<span class=\"_ _0\"></span>yre<span class=\"_ _0\"></span> RS et<span class=\"_ _0\"></span> al. 20<span class=\"_ _3\"></span>1<span class=\"_ _3\"></span>4<span class=\"_ _3\"></span><span class=\"fs1 ls5 v1\">1</span>",
	"kja6iz97Text": "<div style=\"line-height: 1.1;\">A randomised, double-blind, placebo-controlled study of Brintellix® on cognitive<br style=\"\"><span class=\"lsa ws13\">function in depressed adults&nbsp;(FOCUS study).</span><div syle=\"margin-top:5px;\"><span class=\"lsa ws13\" style=\"\"><div style=\"\">Study objective: <span class=\"ff3\" style=\"\">Evaluate the efficacy of Brintellix® 10 and 20 mg/day vs. placebo on</span></div><div class=\"ff3\">cognitive function in adults (aged &lt;65 years) with recurrent major depressive disorder (MDD)</div><div class=\"ff3\">during a depressive episode of moderate severity or greater.</div></span></div></div>",
	"kja6iz98Text": "Key inclusion criteria ",
	"kja6iz99Text": "P<span class=\"_ _c\"></span>atients with a primary<span class=\"_ _0\"></span> <br>diagnosis of recurrent <br>MDD according to <br>DSM-IV criteria ",
	"kja6iz9aText": "18-65 years of age<span class=\"_ _0\"></span> ",
	"kja6iz9bText": "Current MDE dura<span class=\"_ _2\"></span>tion of  <span class=\"_ _e\"> </span> <br>≥3 months ",
	"kja6iz9cText": "MADRS total score of <br>≥26 at screening and <br>baseline",
	"kja6iz9dText": "<div style=\"line-height: 1.2;\"><div style=\"text-align: center;\">F<span class=\"_ _2\" style=\"\"></span>our-week</div><div style=\"text-align: center;\">safety<br style=\"\"></div><div style=\"text-align: center;\">follow up<br style=\"\"></div></div>",
	"kja6iz9gText": "Back",
	"kja6iz9hText": "Brintellix® 20 mg/day (n=207)",
	"kja6iz9iText": "Brintellix® 10 mg/day (n=195)",
	"kja6iz9jText": "Placebo once daily (n=196)",
	"kja6iz9kText": "Randomisation <br><span class=\"ls2a ws85\">1:<span class=\"_ _0\"></span>1:1<span class=\"_ _1\"></span> <br><span class=\"ls49 ws8e\">(A<span class=\"_ _0\"></span>P<span class=\"_ _1\"></span>TS<span class=\"_ _0\"></span> n<span class=\"_ _0\"></span>=<span class=\"_ _0\"></span>598)</span></span>",
	"kja6iz9lText": "Patients seen <br><span class=\"ls39 ws61\">at<span class=\"_ _0\"></span> baseline, <br><span class=\"ls2e ws89\">and week<span class=\"_ _0\"></span>s 1<span class=\"_ _2\"></span>, <br><span class=\"ls1a wsb\">4 and 8</span></span></span>",
	"kja6iz9mText": "Primary ef<span class=\"_ _0\"></span>ficac<span class=\"_ _0\"></span>y analysis: <span class=\"ff3 ls36 wsb\">chan<span class=\"_ _2\"></span>ge from b<span class=\"_ _2\"></span>asel<span class=\"_ _2\"></span>ine t<span class=\"_ _2\"></span>o week 8 <br>in t<span class=\"_ _2\"></span>he com<span class=\"_ _2\"></span>posite z<span class=\"_ _c\"></span>-score<span class=\"_ _2\"></span>, defin<span class=\"_ _2\"></span>ed as the e<span class=\"_ _2\"></span>qua<span class=\"_ _2\"></span>lly we<span class=\"_ _2\"></span>igh<span class=\"_ _2\"></span>ted su<span class=\"_ _2\"></span>m <br>of the z<span class=\"_ _2\"></span>-scor<span class=\"_ _2\"></span>es in the D<span class=\"_ _c\"></span>SST and RAVL<span class=\"_ _3\"></span>T<span class=\"_ _3\"></span>, thus assessin<span class=\"_ _2\"></span>g a broa<span class=\"_ _2\"></span>d <br>range o<span class=\"_ _2\"></span>f cogn<span class=\"_ _2\"></span>itive d<span class=\"_ _2\"></span>oma<span class=\"_ _2\"></span>ins, i<span class=\"_ _2\"></span>nclu<span class=\"_ _2\"></span>din<span class=\"_ _2\"></span>g ex<span class=\"_ _2\"></span>ecutiv<span class=\"_ _2\"></span>e function, <br><span class=\"ls4a ws83\">at<span class=\"_ _0\"></span>tention, proces<span class=\"_ _0\"></span>sing speed, lear<span class=\"_ _0\"></span>ning and memor<span class=\"_ _1\"></span>y<span class=\"_ _c\"></span>.</span></span>",
	"kja6iz9nText": "Secondary ef<span class=\"_ _0\"></span>ficacy analysis: <span class=\"ff3 ls38 ws7e\">change from bas<span class=\"_ _0\"></span>eline to <br></span><span class=\"ff3\">week 8 i<span class=\"_ _2\"></span>n DS<span class=\"_ _2\"></span>ST score (<span class=\"_ _3\"></span>number o<span class=\"_ _2\"></span>f corr<span class=\"_ _2\"></span>ec<span class=\"_ _0\"></span>t symbol<span class=\"_ _2\"></span>s<span class=\"_ _c\"></span>) and <br>R<span class=\"_ _0\"></span>A<span class=\"_ _c\"></span>VL<span class=\"_ _c\"></span>T acquis<span class=\"_ _2\"></span>ition an<span class=\"_ _2\"></span>d del<span class=\"_ _2\"></span>ay<span class=\"_ _2\"></span>ed recal<span class=\"_ _2\"></span>l scor<span class=\"_ _2\"></span>es.</span>",
	"Brintellix_768aff22a2": "<span class=\"ff2 fc0 fs13\">References</span>",
	"Brintellix_76bb0e2df6": "<div class=\"ff3 fc1\" style=\"font-size:15px;\"><span class=\"ff2\">1.</span> McIntyre RS et al. Int J Neuropsychopharmacol 2014;17:1557-1567.</div>",
	"Brintellix_766f7deab5": "<font style=\"font-size: 12px;\"><span style=\"color: rgb(100, 94, 94); font-family: &quot;3_JLVNQG+AvenirNextLTPro-Regular&quot;; letter-spacing: -0.31px; white-space: pre; -webkit-text-stroke: 0.465px rgba(0, 0, 0, 0);\">MDE, major depressive episode; MADRS, Montgomery-Åsberg Depression Rating Scale; DSST, Digit Symbol Substitution Test; RAVLT, Rey Auditory Verbal Learning Test.</span></font>"
}
